X
Access Company Profiles

Get business overview, business operations details specific to this market, products and services, latest developments and more...

Business Email

Select Companies

 

Global Neuroendocrine Tumor Treatment Companies

This report lists the top Global Neuroendocrine Tumor Treatment companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Global Neuroendocrine Tumor Treatment industry.

Global Neuroendocrine Tumor Treatment Top Companies

  1. Pfizer Inc.

  2. Novartis AG

  3. Ipsen

  4. Boehringer Ingelheim International GmbH

  5. Eli Lilly & Company

*Disclaimer: Top companies sorted in no particular order

 Global Neuroendocrine Tumor Treatment Market Major Players

Global Neuroendocrine Tumor Treatment Market Concentration

Global Neuroendocrine Tumor Treatment Market Concentration

Global Neuroendocrine Tumor Treatment Company List

                              • Boehringer Ingelheim International GmbH

                              • Bristol-Myers Squibb

                              • Eli Lilly & Company

                              • F. Hoffmann-La Roche Ltd.

                              • Ipsen

                              • Novartis AG

                              • Pfizer Inc.

                              • Lantheus Holdings, Inc. (Progenics Pharmaceuticals)

                              • Tarveda Therapeutics

                              • AVEO Pharmaceuticals, Inc.

                              • Hutchison MediPharma Limited

                              • Jubilant Life Sciences Ltd.


                          Specific to Global Neuroendocrine Tumor Treatment Market
                          Need More Details On Market Players And Competitors?
                          Download Sample

                          Neuroendocrine Tumor Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)